Atlas Trials

Renohemodynamic Effects of Combined empagliflOzin and LosARtan

Clinical trial NCT04238702 · COMPLETED

Trial details

NCT number
NCT04238702
Sponsor
Amsterdam UMC, location VUmc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Diabetic Kidney Disease
Start date
2020-11-04
Primary completion
2021-09-27
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.